COPD News

Incruse_ellipta_gsk-575
GlaxoSmithKline has received approval from the Japanese Ministry of Health, Labour and Welfare for Encruse Ellipta to treat COPD. The drug has already been approved in the US and Canada under the trade name Incruse Ellipta.
city-walking-work-575
Just over 24% of adults with COPD say they cannot work, compared to about 5% of adults in the general population, and 38% said they found it difficult to walk or climb stairs.
lung-3d-575
New research from the Washington University School of Medicine reveals insight into possibly counteracting inappropriate mucus production in conditions such as asthma and chronic obstructive pulmonary disease (COPD).
doctor examining lung x-ray
Repeated use of roflumilast increases the production of a protein that causes inflammation, which possibly results in COPD patients developing a tolerance to the drug.
astra-500
AstraZenaca's investigational COPD drug PT003 hit its main goals in two late-stage trials, clearing the way for regulatory filings this year in the US and EU.
This image shows inflammed lung tissue with immune cells that have migrated into the lungs. Their nuclei are stained blue.
A new Respirology study has identified certain inflammatory markers that can be used to predict which COPD patients are at the highest risk of dying prematurely.
laptop-stethoscope-500
Mediware's Cardiac and Pulmonary Rehab solution helps support the CMS readmission reduction program, specifically related to COPD.
Image of patient using high-flow nasal cannula.
Patients with COPD and chronic bronchitis had a worse quality of life, symptoms and mental well-being than those patients with chronic airway obstruction, according to study results.
The National Institute for Health and Care Excellence (NICE) has issued a report on COPD care and management guidelines, including extending access to specialist care to decrease the variation in COPD care.
copd-foundation-450
Sponsored by AstraZeneca, COPD360 will combine patient-reported outcomes, clinical data, and EMR into one of the largest COPD research networks ever assembled.
The most common comorbidities observed in COPD patients were cardiovascular disease (34.8%), diabetes (22.8%), and asthma (14.7%). Most patients (52.8%)
There is no cure for COPD, but some patients at the COPD clinic at the University of Colorado Hospital have found that a certain type of music is good medicine.
Gage Skidmore [CC BY-SA 3.0 (http://creativecommons.org/licenses/by-sa/3.0)], via Wikimedia Commons
Multiple news sites are reporting that actor Leonard Nimoy, famed for his role as "Spock" in the TV/film franchise "Star Trek," has died of end-stage COPD.
A study from Brazil found that primary care patients were more familiar with the term “emphysema” (75.1%) than "COPD" (9.2%), a disparity they say was linked to level of education.
Gage Skidmore [CC BY-SA 3.0 (http://creativecommons.org/licenses/by-sa/3.0)], via Wikimedia Commons
According to multiple news reports, "Star Trek" actor Leonard Nimoy, who suffers from COPD, was rushed to UCLA Medical Center on Thursday for “severe chest pains.”
Inhaled corticosteroids are commonly prescribed for asthma and COPD but need careful management to minimize the risk of side effects.
Improving access to specialist care and smoking cessation support are among the actions that can better COPD patient care, according to a national report from the UK.
education-student-350
As healthcare reform and reimbursement procedures grow more complex, integrating COPD navigator education into the curriculum of respiratory care programs is critical to the clinical and career success of students.
researcher-microscope1-500
Compared to COPD, asthma, or cystic fibrosis, Alpha-1 antitrypsin deficiency lung disease is not well known, but dedicated researchers and RTs continue to support patients and work towards finding new treatment options.
lungs
Now available on demand: Learn more about reducing COPD readmissions by watching RT Magazine's free webinar, which features speakers from the COPD Foundation and UC Davis Health System.